Introduction
Cushing's disease has long been identified as a crippling cause of hypercortisolism due to adrenocorticotropic hormone (ACTH)-producing pituitary adenoma.
1,2 Since the late 1970s when endovascular diagnostic techniques were introduced, the differentiation between the two main causes of ACTHdependent Cushing's syndrome has been facilitated. 3, 4 However, a significant number of patients present with a clear diagnosis of a pituitary ACTH elevation in whom no evidence of a pituitary adenoma has been found. 5, 6 Controversy exists regarding the best treatment options for these patients. Some
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Abstract
Object Diagnosis and treatment of Cushing's disease (CD) is a demanding endeavor. We evaluated the effectiveness of inferior petrosal sinus sampling (IPSS) in preoperative tumor lateralization and surgical outcomes. Methods Fifty-two consecutive patients with CD and normal magnetic resonance imaging (MRI) were enrolled between 2009 and 2015. Selective catheterization of petrosal sinuses for IPSS was performed. All patients underwent microsurgical dissection, and if a lesion was found, underwent lesion resection. Demographic, biochemical, and intraoperative findings were prospectively collected and reviewed 6 and 12 months postoperatively. Results Forty-five patients (86.4%) had clear lateralization while seven patients had bilateral elevation. Twenty-two patients (42%) were found to have a macroscopic lesion, defined as an abnormal tissue during microsurgical dissection, which was thus resected. No patient had a lesion larger than 4 mm. Eighty-one percent of patients had the lesion where IPSS had been predicted. Hemi-hypophysectomy was performed on twenty-eight patients based on IPSS findings, since no lesion was found. Eighty-six percent of patients with lesion resection had biochemical remission by 12 months. Biochemical remission was documented in 78 and 71% of patients who underwent hemi-hypophysectomy by 6 and 12 months, respectively. Conclusion With careful microsurgical dissection, a macroscopic lesion could be found in a significant number of patients with normal MRI. When no lesion was found, we recommend performing a hemi-hypophysectomy based on IPSS findings, since prediction accuracy was high and remission rates were significant. authors argue that since no clear lesion has been found, medical management is optimal. 7, 8 Others have advocated for surgical management promoting for a judicious surgical microdissection guided by the results of bilateral inferior petrosal sinus sampling (BIPSS). 9, 10 However, several studies have found a low correlation between BIPSS and tumor lateralization, 11, 12 and several have stated BIPSS cannot be used to accurately lateralize lesions within the pituitary.
13,14
The fact that several reputed authors have published their own treatment algorithm including BIPSS shows that while useful as a diagnostic tool, its true effectiveness in preoperative planning and prognosis is yet to be ascertained. We present a series of 52 consecutive patients with a confirmed diagnosis of Cushing's disease without any abnormalities in 3T MRI, their intraoperative findings, and postoperative results in an effort to clarify the role of BIPSS as a surgical planning tool and its relevance as a prognostic factor. The results of the study can assist surgeons and patients by providing an additional tool in the treatment decision process and provide further evidence on the usefulness, or lack thereof, of BIPSS.
Methods Enrollment and Inclusion Criteria
Prior to patient enrollment, institutional evaluation and approval was obtained at both Hospital Universitario San Ignacio and Fundación Cardioinfantil-Instituto de Cardiología. Informed consent for enrollment was waived. A multidisciplinary team comprising an endocrinologist and skull base and endovascular neurosurgeons evaluated all the patients with suspicion of Cushing's disease. The diagnosis of Cushing's disease (CD) was made by up-to-date guidelines. 15 Patients without a clear diagnosis of CD or in whom a peripheral cause of hypercortisolism was suspected were excluded. Dynamic, contrast-enhanced 3T MRI of the sellar region was performed in all patients; MRI studies were independently reviewed by a neuroradiologist who was blinded to the objectives and outcomes of the study. Patients with CD and no enhancing lesions or abnormal findings in contrast-enhanced MRI were enrolled between 2009 and 2015. Patients with prior surgical intervention in the sellar region, adrenalectomy or Nelson's syndrome, and patients who did not authorize their enrollment were excluded from the study. Fifty-two consecutive patients (44 females/8 males; mean age: 34.8 years) who fulfilled the inclusion criteria and authorized their enrollment underwent bilateral inferior petrosal sinus (IPSS) catheterization with corticotrophin releasing hormone (CRH) stimulation.
Intervention
IPSS was performed using the same technique in all patients. The detailed description is as follows: The procedure was performed under local anesthetic in an angiography suite with an endovascular specialist, a surgical assistant performing the procedure, and three nurses for correct sample confirmation and labeling. Bilateral femoral vein access was obtained using anatomical landmarks or ultrasound evaluation and a 5 Fr introductory sheath was placed on each side.
The patient was then administered 5,000 U bolus of unfractionated heparin before a 5 Fr Envoy catheter (Codman Neuro, Raynham, Massachusetts, United States) was advanced to the internal jugular vein and a 2.8 Fr Progreat microcatheter was placed over a Glidewire Gold 0.014″ guidewire (Terumo Medical Corp., Somerset, New Jersey, United States) to obtain selective catheterization of the inferior petrous sinus on both sides using contrast-reflux technique to visualize the IPS. Although described in the literature, we found all IPS drained into the jugular bulb and not into the vertebral venous plexus. 16 Once adequate positioning was verified with an angiographic evaluation, baseline samples were taken from both microcatheters and a peripheral IV line. Microcatheter samples were taken by the surgeon and the surgical assistant and passed on to individual unscrubbed nurses for labeling. The peripheral sample was taken from a peripheral venous catheter placed on either the cephalic or basilica vein on the patient's forearm (different from the IV line used for medication administration) by a third nurse and labeled accordingly. Afterward, a single 100 mg dose of CRH (Ferring Pharmaceuticals. Saint-Prex, Switzerland) was administered intravenously. Samples were then taken using the same method as the baseline at 3-, 5-and 10-minute intervals. All 12 samples (three each at baseline; 3, 5, and 10-minute intervals) were immediately send to the laboratory for processing of ACTH levels. Patients were considered to have Cushing's disease when a threefold difference was found between peripheral and central (IPS) measurements after CRH-induction. 17 This was measured as a confirmation of CD, since all patients enrolled had already been diagnosed using alternate tests, 18 and the accuracy of IPSS for CD diagnosis was beyond the scope of this study. Patients who had a 50% difference between sides were considered to have a significant lateralization, while patients were deemed to have no lateralization when both sides had a significant (threefold) increase in comparison with peripheral measurement; however, no significant differences were found between the sides.
12
All patients underwent microsurgical exploration, and if found, the lesion was resected. Although all patients had the IPSS performed by the senior author (J.C.P.) due to intricacies of the Colombian Healthcare system, not all patients were operated on by the same neurosurgeon. A macroscopic lesion was defined as an abnormal tissue found during microsurgical dissection, usually an abnormal discoloration of pituitary tissue. The term, macroscopic lesion (an abnormal tissue found during surgical dissection), should not be confused with the term macroadenoma meaning a pituitary tumor over 10 mm in size. This semantic difference is paramount, since all the patients enrolled had no tumor on preoperative imaging. Had they been found to have a macroadenoma, BIPSS would have been futile, since the location of the tumor would have been obvious. When a macroscopic lesion was not found during careful transsphenoidal dissection (either via an endoscopic or microsurgical technique), hemi-hypophysectomy was performed based on IPSS findings on all but two of the patients who had only authorized resection, if a lesion was found. Specific details on surgical technique for hemi-hypophysectomy are beyond the scope of this study.
Outcome Measures
IPSS results were compared with intraoperative findings and differences were noted. If clear lateralization was found during IPSS, the patient was expected to have either a lesion on the side predicted or disease remission after hemi-hypophysectomy for IPSS correlation was considered significant. Disease remission was considered as a blood cortisol level below 5 ng/dL in a fasting sample at both 6-and 12-month evaluations. Improvement of prior symptoms of hypercortisolism were noted but not evaluated as an outcome measure, since diminishing blood cortisol level could improve symptoms without true freedom from disease. Patients with disease recurrence were those with a blood cortisol level below 5 ng/dL at the 6-month evaluation and had subsequent elevation above the said cutoff point before the 12-month follow-up. A blood cortisol level above 5 ng/dL at immediate postoperative evaluation or at 6-month follow-up was considered persistence of the disease.
Data Collection and Statistical Analysis
Demographic, biochemical, sampling results, intraoperative findings, and imaging data were prospectively collected and retrospectively reviewed 6 and 12 months after surgery. Since patients were operated on by their treating neurosurgeon and biopsy specimens were evaluated in several different institutions without a standardized evaluation method, in many cases without immuno-histochemical analysis, histological results were not included in our analysis. All patient information and data, without patient identifiers, were stored in a single encoded database using Microsoft Excel 2013 (Microsoft Corp. Seattle, Washington, United states). The senior author noted IPSS results after performing the procedure. Two authors (P.H. and M.G.G.) who were blinde to the IPSS findings evaluated the postoperative results. After all the data were collected, a correlation between both IPSS and postoperative results was performed by consensus between all the authors.
Results
Fifty-two patients were enrolled into the study. A total of 215 patients were operated on for CD at both institutions during this timeframe. All patients enrolled underwent IPSS that was performed by the senior author (J.C.P.) in two institutions. ►Table 1 shows demographic and intraoperative findings in patients with and without clear lateralization in IPSS. Correlation between IPSS results and intraoperative findings are also shown. Forty-five patients (86.4%) had a clear lateralization with 25 (48%) and 20 patients (38.4%) having right-and left-sided elevations, respectively. Seven patients (14.6%) had bilateral ACTH elevation suggesting a midline lesion. Twenty-two patients (42.3%) were found to have a lesion after a careful dissection was performed. Correlation between IPSS results and intraoperative findings was considered when a lesion was found on the side predicted by IPSS (or when a midline lesion was found on a bilaterally elevated IPSS), while a negative correlation was noted when the lesion was either contralateral to the side predicted or midline with a clearly lateralized IPSS result. A very high percentage (81%) of patients were found to have a lesion on the location the IPSS had predicted. Nineteen patients who had a lesion excised (86%) were disease free by 12 months postoperatively. Two patients (9%) had a nonsignificant decline in blood cortisol levels at postoperative and at 6-month follow-up and were thus considered to have disease persistence. Only one patient (5%) had a significant decline in blood cortisol levels on postoperative and 6-month evaluation but had recurrence 8 months after surgery (►Table 1).
Thirty patients (57.7%) had no macroscopic lesions during surgical dissection. A hemi-hypophysectomy was performed on all but two of these patients who had given consent to careful dissection and surgical excision only if a lesion was found. Twenty-two patients (78.5%) who underwent hemihypophysectomy were disease free after 6 months with two of these patients having recurrence at 7 and 10 months for a 71.4% cure rate at 12 months.
Patients who had clear lateralization, with or without a macroscopic lesion, had a freedom-of-disease rate of 81.4 and 76.7% at 6 and 12 months, respectively. On the other hand, if patients had bilateral ACTH elevation after CRH induction, the cure rate at 6 and 12 months was 71.4 and 57.1% (p-value ¼ 0.075), respectively (►Fig. 1).
Discussion
The role of BIPSS in the diagnosis of CD varies between centers, and many different authors have published their own treatment algorithm regarding CD. Our results show that BIPSS has a very robust role in the diagnostic workup and preoperative planning in a very select, but difficult to treat, group of patients. We believe our results are encouraging for both patients and specialists facing a central hypercortisolism without any abnormal findings in MRI.
Our results showed a positive predictive value of 86% in patients in whom a macroscopic lesion was found and an overall positive predictive value (PPV) of 71%. These findings are similar to other studies published in the literature. Lui et al evaluated the diagnostic accuracy of BIPPS in 61 patients with a 65% correlation coefficient, 19 while Gazioglu et al evaluated the accuracy of CSS with an 85% positive predictive value after CRH stimulation. 12 Nevertheless, a significant number of patients had a clearly lateralized sampling and were found to have a contralateral macroscopic lesion 20 or as described previously in several case reports, patients may have several lesions. 21, 22 However, in patients with a high burden of disease in whom no lesion was found and had been on one or more pharmacological treatment trials, BIPSS and a very thorough microsurgical dissection were shown to have a 71% cure rate at 12 months. Although one would like this figure to be higher, having a two-thirds cure rate in a very challenging disease where several other alternatives that have failed must be taken into account and considered appropriately. However, even if microsurgical dissection should be guided by BIPSS results and no lesions are found on the side predicted, the dissection must be performed throughout the gland, since finding and excising a macroscopic lesion yield a much better prognosis. Nevertheless, our study has several limitations. First and foremost, it is a retrospective review of a heterogeneous study population. The fact that patients were operated on by different surgeons also limits the homogeneity of the sample. However, we believe that surgeon expertise, a confounding factor common to most studies including surgical interventions, is not a significant factor in our evaluation. A larger sample and possibly a randomized trial would be of great utility in ultimately terminating the controversy of the utility of BIPSS in this patient population; however, the infrequency of this diagnosis and potential ethical considerations could limit the amount of future research.
Conclusion
BIPSS must be considered as an indispensable tool in the diagnostic and treatment armamentarium of endocrinologists, neuroradiologists, and neurosurgeons. We believe it has specific utility in preoperative evaluation, especially if no radiologic abnormalities are found in high-power MRI. Therefore, our results show that patients confirmed to have Cushing's disease without clear radiologic evidence of an ACTH-producing lesion should be taken to BIPSS to guide the best treatment course both in preoperative planning and intraoperative decision making. The role of BIPSS as a diagnostic tool was not evaluated as it has been previously studied. Further evidence is required to clarify the role of BIPSS as a stand-alone prognostic factor.
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